fashion -WSS

fashion

author：Wikipedia 2025-10-04 04:01:59 - browse：356

Two hands hold a box of four Wegovy pens — first opinion coverage from STAT — Cydni Elledge/The New York Times

The news about anti-obesity drugs keeps getting better. In November, data presented at the American Heart Association meeting added cardiovascular benefit to value in combating obesity and diabetes. This comes on the heels of news that Novo Nordisk halted a clinical trial to test Wegovy’s impact on renal function early because the results they were seeing were so strong.

Yet beneath the hype lies a real fear. Unless we reverse the rising tide of metabolic syndrome, Medicare will be crushed, with tens of millions of Americans having shorter, harder lives. The new drugs offer the first real chance to deploy at scale treatments to halt a seemingly unstoppable trend.

That will be costly. But so is the status quo. Medicare spending on people with advanced metabolic disease is sobering. Beneficiaries with two or more of the costliest conditions — diabetes, heart failure, or chronic kidney disease — comprise just 10% of beneficiaries, according to the NIH’s Renal Data System 2022 Annual Data Report. Yet they account for 25% of total costs. Those with all three conditions are 2% of beneficiaries but almost 7% of costs. And remember, the current cohort of Medicare beneficiaries turned 65 when obesity and diabetes rates were lower, meaning unless we do something dramatic, and fast, these percentages will balloon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： White House drug shortages task force keeps mum with Congress

explore

hotspot

WSS

Congress: Prevent baby formula shortages by passing a new bill

Achieving telehealth equity for people with hearing loss

Clinicians often fail to acknowledge the pain caused by long Covid

Lawsuit challenges CMS nursing home minimum staffing rule

Medical students need to learn the potent medicine of empathy

Why some fertility treatments produce more boy babies

explore

fashion

entertainment

Walensky prepares to leave CDC — and Congress — behind

Bird flu makes raw milk dangerous to consume, mouse study finds

After affirmative action ruling, medical educators look to 'holistic review'

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

At least 13 dead in Texas as scorching temps continue

Louisiana bill approved classifying abortion pills as controlled substances

Bright Health sells Medicare Advantage business to Molina

Genentech weighs delaying cancer therapy after drug pricing law

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Beyond aggravation: Constipation is an American epidemic

Wikipedia

Why we need mandatory labeling of GMO products

Maui funeral service workers on devastation of fires: 'I'm in shock'

Where are patients getting their prescriptions for GLP

GOP presidential candidates start declaring their loyalty

J&J reports mixed data on next

The Bio Revolution is changing business and society

explore

leisure time

hotspot

entertainment